Melief CJ - Search Results

1

Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH. Welters MJ, et al. Among authors: melief cj. Clin Cancer Res. 2008 Jan 1;14(1):178-87. doi: 10.1158/1078-0432.CCR-07-1880. Clin Cancer Res. 2008. PMID: 18172269 Clinical Trial.

2

Lessons from T cell responses to virus induced tumours for cancer eradication in general.

Melief CJ, Kast WM. Melief CJ, et al. Cancer Surv. 1992;13:81-99. Cancer Surv. 1992. PMID: 1423326 Review.

3

In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes.

Kast WM, Melief CJ. Kast WM, et al. Among authors: melief cj. Immunol Lett. 1991 Oct;30(2):229-32. doi: 10.1016/0165-2478(91)90030-e. Immunol Lett. 1991. PMID: 1757108 Review.

4

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, van der Eb AJ, Melief CJ. Kast WM, et al. Among authors: melief cj. Cell. 1989 Nov 17;59(4):603-14. doi: 10.1016/0092-8674(89)90006-8. Cell. 1989. PMID: 2555063

5

Immunosurveillance of virus-induced tumors.

Melief CJ, Vasmel WL, Offringa R, Sijts EJ, Matthews EA, Peters PJ, Meloen RH, van der Eb AJ, Kast WM. Melief CJ, et al. Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:597-603. doi: 10.1101/sqb.1989.054.01.071. Cold Spring Harb Symp Quant Biol. 1989. PMID: 2700948 Review. No abstract available.

6

Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2.

Kast WM, Brandt RM, Drijfhout JW, Melief CJ. Kast WM, et al. Among authors: melief cj. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):115-20. doi: 10.1097/00002371-199308000-00006. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506573

7

Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides.

Nijman HW, Houbiers JG, van der Burg SH, Vierboom MP, Kenemans P, Kast WM, Melief CJ. Nijman HW, et al. Among authors: melief cj. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):121-6. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506574

8

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A. Kast WM, et al. Among authors: melief cj. J Immunol. 1994 Apr 15;152(8):3904-12. J Immunol. 1994. PMID: 7511661

9

An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene.

Toes RE, Offringa R, Blom RJ, Brandt RM, van der Eb AJ, Melief CJ, Kast WM. Toes RE, et al. Among authors: melief cj. J Immunol. 1995 Apr 1;154(7):3396-405. J Immunol. 1995. PMID: 7534797

10

Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.

van der Burg SH, Klein MR, van de Velde CJ, Kast WM, Miedema F, Melief CJ. van der Burg SH, et al. Among authors: melief cj. AIDS. 1995 Feb;9(2):121-7. AIDS. 1995. PMID: 7536421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page